(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 195.75 | 166.41 | 152.66 | 17.6% | 28.2% |
Total Expenses | 170.57 | 152.56 | 141.74 | 11.8% | 20.3% |
Profit Before Tax | 25.18 | 13.86 | 10.92 | 81.7% | 130.6% |
Tax | 6.56 | 3.46 | 2.88 | 89.6% | 127.8% |
Profit After Tax | 18.62 | 10.40 | 8.04 | 79.0% | 131.6% |
Earnings Per Share | 3.90 | 2.10 | 1.70 | 85.7% | 129.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Kopran Ltd is a pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of generic and branded pharmaceutical products. The company's portfolio includes formulations and active pharmaceutical ingredients (APIs) that cater to various therapeutic segments. Kopran Ltd operates within the pharmaceutical industry, which is characterized by high levels of research and development activities and stringent regulatory requirements. As of the data available, there are no specific recent major developments mentioned for Kopran Ltd. The company's focus on innovation and expanding its product offerings remains integral to its operations.
During Q4FY25, Kopran Ltd reported a total income of ₹195.75 crores, reflecting a significant increase compared to ₹166.41 crores in Q3FY25 and ₹152.66 crores in Q4FY24. The quarter-over-quarter (QoQ) growth in total income was 17.6%, while the year-over-year (YoY) increase was 28.2%. This strong revenue growth highlights the company's ability to enhance its sales performance over both the short and long term. The increase in total income during this period suggests an effective strategy in capturing market demand or expanding market share.
Kopran Ltd's profitability demonstrated robust growth in Q4FY25. The company recorded a profit before tax of ₹25.18 crores, which was an 81.7% increase QoQ from ₹13.86 crores in Q3FY25 and a substantial 130.6% increase YoY from ₹10.92 crores in Q4FY24. After accounting for taxes, the profit after tax stood at ₹18.62 crores, marking a 79.0% increase QoQ and a 131.6% rise YoY. The significant improvement in profitability is further reflected in the earnings per share (EPS), which increased to ₹3.90 from ₹2.10 in the previous quarter and ₹1.70 in the same quarter last year, showing an 85.7% QoQ and 129.4% YoY growth.
Total expenses for Kopran Ltd in Q4FY25 amounted to ₹170.57 crores, up from ₹152.56 crores in Q3FY25 and ₹141.74 crores in Q4FY24. This represents an 11.8% increase QoQ and a 20.3% rise YoY. The increase in expenses is consistent with the company's revenue growth, indicating that operational scaling might be underway to support increased production or service delivery. The tax outlay also increased by 89.6% QoQ and 127.8% YoY, aligning with the rising profit levels. The financial data reflects strong operational performance, with both revenue and expenses growing, yet profitability significantly outpacing cost increases.